logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9463184 B1

PDFFull Text
Date of Patent:
Oct. 11, 2016

Filed:

Nov. 13, 2013

Calcium flux agonists and methods thereof

Applicant:

Nant Holdings Ip, Llc, Los Angeles, CA (US);

Inventors:

Kayvan Niazi, Los Angeles, CA (US);

Shahrooz Rabizadeh, Los Angeles, CA (US);

Justin Golovato, Los Angeles, CA (US);

Patrick Soon-Shiong, Los Angeles, CA (US);

Anne-Laure Le Ny, South Pasadena, CA (US);

Oleksandr Buzko, Los Angeles, CA (US);

Assignee:

Nant Holdings IP, LLC, Culver City, CA (US);

Attorney:

Fish & Tsang, LLP

Primary Examiner:

Jeffrey H Murray

Int. Cl.
CPC ...
A01N 43/76 (2006.01); A61K 31/42 (2006.01); A01N 43/08 (2006.01); A61K 31/34 (2006.01); A01N 43/20 (2006.01); A01N 43/24 (2006.01); A61K 31/335 (2006.01); A61K 31/423 (2006.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/365 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 33/24 (2006.01); A61K 9/00 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2006.01); A61K 31/341 (2006.01); A61K 31/16 (2006.01); A61K 31/66 (2006.01);
U.S. Cl.
CPC ...
A61K 31/423 (2013.01); A61K 9/0014 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/16 (2013.01); A61K 31/341 (2013.01); A61K 31/365 (2013.01); A61K 31/404 (2013.01); A61K 31/407 (2013.01); A61K 31/66 (2013.01); A61K 33/24 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01);
Abstract

Calcium flux agonists are used to enhance a TLR- or NOD-mediated stimulus and to so increase an immune response of a host and reduce healing time. Preferred calcium flux agonists include Caionophores and SERCA inhibitors and are used in synergistic quantities where a ligand to a TLR or NOD receptor is present.

Find Patent Forward Citations

Niazi, Kayvan. (2016). Calcium flux agonists and methods thereof (U.S. Patent No. 9463184). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9463184

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…